Our best wishes for the Holiday Season
Did 2024 fly by as quickly for you as it did for us? It wasn’t all a walk
News
An interview with Cinzia Silvestri, Scientist Founder of Bi/ond
In this interview series, Leonardo Massa showcases scientists’ journey toward founding groundbreaking tech startups. Read the conversation with
Bridging Dutch biotech excellence with global entrepreneurial opportunities – panel discussion
Join us next week for Nucleate’s exciting event, where our CEO, Cinzia Silvestri, will participate in a panel
Join Cinzia Silvestri at the Ladies Intro from TU Delft Welcome Commitee (OWee)
Our CEO, Cinzia Silvestri, will share her entrepreneurial success story with 400 incoming female students at TU Delft
Bi/ond and bit.bio collaboration generates 3D in vitro model for studying Duchenne Muscular Dystrophy (DMD)
By creating a functional 3D in vitro model using cells with a DMD-causing mutation, this Bi/ond and bit.bio
Bi/ond to Support Muscle Mitophagy Drug Development Programs as a Recipient of the Latest Eurostars Grant Award
Consortium to generate pre-clinical data for muscle disfunction drug candidate Delft, The Netherlands – 13 February 2024 –
Bi/ond and the Journey to Personalized Medicine
Bi/ond has been featured in the SME Focus section of the latest Inside* industry magazine. The article highlights
Cinzia Silvestri – Females to Follow Nominee
Our CEO, Cinzia Silvestri, is nominated to the TOPX Females to Follow Awards in the category Rising Stars
On Demand Webinar: Advancements in 3D modeling – Building mature, functional 3D skeletal muscle microtissues in vitro
If you missed the live session, or want to go back to some of the key aspects of
